MICROPORT CARDIOFLOW MEDTECH CORPORATION

MicroPort CardioFlow Medtech Corporation

2160

KYG6082P1054

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:16 2024-04-24 am EDT			5-day change	1st Jan Change
0.98 ^HKD	+1.03%		+4.26%	-39.51%

Apr. 16	Microport Cardioflow Inks Services Deal with Subsidiary	MT
Apr. 15	MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement	CI

MicroPort CardioFlow Medtech Corporation(SEHK:2160) added to S&P Global BMI Index

June 21, 2021 at 12:00 am EDT

Latest news about MicroPort CardioFlow Medtech Corporation

Microport Cardioflow Inks Services Deal with Subsidiary	Apr. 16	MT
MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement	Apr. 15	CI
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
MicroPort CardioFlow Medtech Corporation Provides Consolidated Revenue Guidance for the Year Ended December 31, 2023	Feb. 28	CI
China Approves MicroPort CardioFlow's Application for Atrial Appendage Closure System; Shares Fall 3%	Jan. 07	MT
Microport Cardioflow Medtech Corporation Receives NMPA Approval for Registration Application of Anchorman LAAC System	Jan. 07	CI
MicroPort CardioFlow Subsidiary to Buy 51% Stake in Medical Device Maker	Jan. 02	MT
MicroPort CardioFlow Medtech to Renew Four Agreements With Parent	Dec. 07	MT
MicroPort's Transcatheter Aortic Heart-Valve Implantation Product Completes Seven Trials in Europe	23-10-25	MT
MicroPort CardioFlow Medtech Corporation Completes Clinical Implantation Cases in Europe	23-10-25	CI
MicroPort CardioFlow's Transcatheter Aortic Heart Valve Implantation Device Enters Clinical Application Phase	23-10-16	MT
MicroPort CardioFlow Medtech Corporation Announces First Two Clinical Applications of Third-Generation TAVI Product	23-10-16	CI
Transcript : MicroPort CardioFlow Medtech Corporation, H1 2023 Earnings Call, Aug 31, 2023	23-08-31
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
MicroPort Cardioflow Medtech Corporation Announces Executive Changes	23-08-29	CI
MicroPort Cardioflow Medtech Corporation Announces Executive Changes	23-08-29	CI
Microport Cardioflow Medtech Corporation Announces Change of Directors and Chairman,Change in Composition of Board Committees,Change of President and Change of Authorised Representative	23-08-29	CI
MicroPort CardioFlow's TMVR System Passes Clinical Trials	23-08-07	MT
MicroPort CardioFlow Medtech Corporation Announces Self-Developed TMVR System Achieved Excellent Follow-Up Results in Multiple Clinical Application Cases	23-08-06	CI
MicroPort CardioFlow Medtech to Grant 10 Million Share Options	23-04-03	MT
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
MicroPort CardioFlow Medtech to Widen 2022 Loss	23-03-01	MT
MicroPort CardioFlow Medtech Corporation Provides Group Earnings Guidance for the Year Ended December 31, 2022	23-02-28	CI
MicroPort CardioFlow's Products Registered in Thailand	23-02-22	MT
MicroPort CardioFlow Medtech Unit Procures Catering, Property Management Services	23-01-18	MT

Chart MicroPort CardioFlow Medtech Corporation

Duration

Period

Chart MicroPort CardioFlow Medtech Corporation

More charts

Microport Cardioflow Medtech Corp is a China-based investment holding company mainly engaged in the medical device industry. The Company is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The Company's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The Company mainly conducts business within the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for MicroPort CardioFlow Medtech Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.8968 CNY

Average target price

2.412 CNY

Spread / Average Target

+168.99%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
MICROPORT CARDIOFLOW MEDTECH CORPORATION	-39.51%	299M
STRYKER CORPORATION	+11.84%	127B
SMITH & NEPHEW PLC	-8.50%	10.68B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.71%	8.59B
INSPIRE MEDICAL SYSTEMS, INC.	+14.99%	7.09B
GLAUKOS CORPORATION	+27.16%	5.07B
AXONICS, INC.	+6.81%	3.39B
ENOVIS CORPORATION	-0.98%	3.04B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-13.77%	2.02B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-9.83%	2B

Medical Devices & Implants